Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 2

Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)

       
Total article views   HTML views PDF downloads Totals
6,490 Dovepress* 6,490+ 2,237 8,727
Totals 6,490 2,237 8,727
*Since 15 May 2007
+Since July 2016

View citations on Google Scholar